Literature DB >> 8791177

A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients.

H Verdoux1, B Gonzales, N Takei, M Bourgeois.   

Abstract

Survey questionnaires were mailed to public hospital psychiatrists practising in a French region to obtain information on the manic-depressive outpatients they personally followed up. Data were collected on 222 manic-depressive outpatients managed by 43 separate psychiatrists. More than two thirds were receiving at least one antipsychotic, and 17% were prescribed a depot-neuroleptic. Predictors of antipsychotic prescription were a history of psychotic features (OR = 3.4; 95%CI 1.7-6.9), early age at onset (OR = 2.1; 95%CI 1.0-4.8) and low educational level (OR = 3.1; 95%CI 1.5-6.3). Similar predictors were found for depot-neuroleptic prescription. Although these indicate that the prescription of antipsychotic for manic-depressive outpatients is not random, only 14% of patients were receiving mood stabilizers only. Owing to the potential side effects of antipsychotics, the benefit-to-risk ratio of antipsychotic use in the maintenance treatment of manic-depressive patients has to be carefully taken into account.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791177     DOI: 10.1016/0165-0327(95)00084-4

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

Review 1.  Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.

Authors:  J M Russell; J A Mackell
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Atypical antipsychotics and mood stabilization in bipolar disorder.

Authors:  Paolo Brambilla; Francesco Barale; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

3.  Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service.

Authors:  Sabrina Paterniti; Jean-Claude Bisserbe
Journal:  BMC Psychiatry       Date:  2013-08-13       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.